A structured framework for AI-assisted stock screening, disciplined stock diagnosis,
and repeatable technical strategy training.
We decode market data through research-based records rather than intuition,
so every observation becomes a testable skill.
This page is provided for educational and learning purposes only. It is not investment advice.
Framework · Records · Simulation
Training to read screening output in context, understanding why a name appears and what the result cannot tell you.
Turning raw observations into a structured diagnosis record that can be reviewed, compared, and learned from.
Reducing noise, isolating meaningful patterns, and practicing technical setups with a written rule set.
Real-time discussion and peer review accelerate the feedback loop that solo study rarely provides.
Instead of simply looking at a chart, we separate hypothesis from evidence and record both in a repeatable format. That repetition is what produces consistent progress. Every case study is worked through on a simulated portfolio of $20,000 or more, purely as a learning exercise.
Training to read screening output through context and market phase, not as an isolated number.
Converting raw notes and chart observations into a diagnosis record that can actually be studied.
Reducing noise and connecting meaningful patterns to a clearly written technical rule set.
Separate observation, hypothesis, evidence, and conclusion into a repeatable written format.
Read global indices, news flow, and price data inside their proper market context.
Signal versus noise, condition versus outcome, correlation versus causation.
Test hypotheses on a simulated portfolio of $20,000 or more as a paper exercise only.
Practice survival first: loss limits, position sizing, and written execution rules.
Strengthen your decision framework through a standardized dashboard perspective.
Real-time discussion and sharing inside the community surface things that are hard to find on your own. Members review how each other tested an idea and give structured feedback. This is a learning loop, not a performance promise. Case reviews are conducted on simulated portfolios of $20,000 or more.